Brighthouse [BHF] vs MetLife [MET] Detailed Stock Comparison

Brighthouse

MetLife
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Brighthouse wins in 12 metrics, MetLife wins in 5 metrics, with 0 ties. Brighthouse appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Brighthouse | MetLife | Better |
---|---|---|---|
P/E Ratio (TTM) | 6.07 | 13.98 | Brighthouse |
Price-to-Book Ratio | 0.53 | 1.98 | Brighthouse |
Debt-to-Equity Ratio | 160.02 | 172.25 | Brighthouse |
PEG Ratio | 0.01 | -0.74 | MetLife |
EV/EBITDA | N/A | 10.02 | N/A |
Profit Margin (TTM) | 8.24% | 5.87% | Brighthouse |
Operating Margin (TTM) | 14.15% | 5.61% | Brighthouse |
EBITDA Margin (TTM) | 14.15% | 5.61% | Brighthouse |
Return on Equity | 13.46% | 15.51% | MetLife |
Return on Assets (TTM) | 0.65% | 0.59% | Brighthouse |
Free Cash Flow (TTM) | $-290.00M | $14.60B | MetLife |
Dividend Yield | N/A | 2.10% | N/A |
1-Year Return | 10.57% | -3.70% | Brighthouse |
Price-to-Sales Ratio (TTM) | 0.38 | 0.75 | Brighthouse |
Enterprise Value | $4.78B | $72.64B | MetLife |
EV/Revenue Ratio | 0.59 | 1.00 | Brighthouse |
Revenue per Share (TTM) | $137 | $106 | Brighthouse |
Earnings per Share (Diluted) | $8.75 | $5.89 | Brighthouse |
Beta (Stock Volatility) | 0.86 | 0.85 | MetLife |
Brighthouse vs MetLife Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Brighthouse | -3.84% | -6.49% | 17.66% | 0.67% | 6.71% | 6.36% |
MetLife | -0.02% | 0.34% | 3.45% | 4.00% | 18.76% | 0.70% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Brighthouse | 10.57% | 4.96% | 60.81% | -25.94% | -25.94% | -25.94% |
MetLife | -3.70% | 26.46% | 109.65% | 89.18% | 135.55% | 96.87% |
News Based Sentiment: Brighthouse vs MetLife
Brighthouse
News based Sentiment: MIXED
October saw a surge in takeover speculation for Brighthouse Financial, driven by activist investor pressure and reports of a potential deal. This is balanced by recent earnings disappointments and mixed technical signals, creating a complex investment scenario with both significant upside potential and underlying risks.
MetLife
News based Sentiment: POSITIVE
MetLife demonstrated a strong focus on digital transformation throughout October, highlighted by the TTX conference and faster policy delivery in Bangladesh. Coupled with positive analyst reports indicating undervaluation and solid long-term performance, the month paints a positive picture for investors, suggesting a company well-positioned for future growth.
Performance & Financial Health Analysis: Brighthouse vs MetLife
Metric | BHF | MET |
---|---|---|
Market Information | ||
Market Cap | $3.18B | $54.78B |
Market Cap Category | Mid cap | Large cap |
10 Day Avg. Volume | 1,569,810 | 3,549,360 |
90 Day Avg. Volume | 1,429,980 | 3,504,690 |
Last Close | $51.04 | $82.35 |
52 Week Range | $42.07 - $64.12 | $65.21 - $89.05 |
% from 52W High | -20.40% | -7.52% |
All-Time High | $75.00 (Jul 17, 2017) | $89.05 (Nov 25, 2024) |
% from All-Time High | -31.95% | -7.52% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.39% | -0.03% |
Quarterly Earnings Growth | 1.50% | -0.23% |
Financial Health | ||
Profit Margin (TTM) | 0.08% | 0.06% |
Operating Margin (TTM) | 0.14% | 0.06% |
Return on Equity (TTM) | 0.13% | 0.16% |
Debt to Equity (MRQ) | 160.02 | 172.25 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $99.31 | $41.52 |
Cash per Share (MRQ) | $131.16 | $45.83 |
Operating Cash Flow (TTM) | $51.00M | $15.23B |
Levered Free Cash Flow (TTM) | $-1,421,500,032 | $3.00B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 2.10% |
Last 12-Month Dividend | N/A | $1.65 |
Valuation & Enterprise Metrics Analysis: Brighthouse vs MetLife
Metric | BHF | MET |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 6.07 | 13.98 |
Forward P/E | 2.66 | 8.50 |
PEG Ratio | 0.01 | -0.74 |
Price to Sales (TTM) | 0.38 | 0.75 |
Price to Book (MRQ) | 0.53 | 1.98 |
Market Capitalization | ||
Market Capitalization | $3.18B | $54.78B |
Enterprise Value | $4.78B | $72.64B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.59 | 1.00 |
Enterprise to EBITDA | N/A | 10.02 |
Risk & Other Metrics | ||
Beta | 0.86 | 0.85 |
Book Value per Share (MRQ) | $99.31 | $41.52 |
Financial Statements Comparison: Brighthouse vs MetLife
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | BHF | MET |
---|---|---|
Revenue/Sales | $790.00M | $17.18B |
Cost of Goods Sold | N/A | N/A |
Gross Profit | N/A | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | N/A |
EBITDA | N/A | N/A |
Pre-Tax Income | $93.00M | $980.00M |
Income Tax | $8.00M | $245.00M |
Net Income (Profit) | $85.00M | $735.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | BHF | MET |
---|---|---|
Cash & Equivalents | $4.67B | $21.33B |
Total Current Assets | N/A | N/A |
Total Current Liabilities | N/A | N/A |
Long-Term Debt | $3.16B | $18.85B |
Total Shareholders Equity | $5.30B | $27.76B |
Retained Earnings | $-1.39B | $43.13B |
Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | BHF | MET |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | $146.00M | $4.26B |
Debt Repayment | N/A | $-810.00M |
Common Stock Repurchase | $-59.00M | $-1.41B |
Short Interest & Institutional Ownership Analysis
Metric | BHF | MET |
---|---|---|
Shares Short | 2.93M | 9.86M |
Short Ratio | 3.56 | 3.56 |
Short % of Float | 0.07% | 0.02% |
Average Daily Volume (10 Day) | 1,569,810 | 3,549,360 |
Average Daily Volume (90 Day) | 1,429,980 | 3,504,690 |
Shares Outstanding | 58.63M | 689.21M |
Float Shares | 56.44M | 554.68M |
% Held by Insiders | 0.01% | 0.00% |
% Held by Institutions | 0.87% | 0.92% |
Dividend Analysis & Yield Comparison: Brighthouse vs MetLife
Metric | BHF | MET |
---|---|---|
Last 12-Month Dividend | N/A | $1.65 |
Last 12-Month Dividend Yield | N/A | 2.10% |
3-Year Avg Annual Dividend | N/A | $1.93 |
3-Year Avg Dividend Yield | N/A | 0.77% |
3-Year Total Dividends | N/A | $5.78 |
Ex-Dividend Date | N/A | Feb 04, 2025 |